✦ LIBER ✦

Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines

✍ Scribed by Anna Ansell; Fredrik Jerhammar; Rebecca Ceder; Roland Grafström; Reidar Grénman; Karin Roberg

Book ID: 113833178
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 255 KB
Volume: 45
Category: Article
ISSN: 1368-8375
DOI: 10.1016/j.oraloncology.2009.02.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O113. Matrix metalloproteinase-7 and -13

O113. Matrix metalloproteinase-7 and -13 predict response to cisplatin in head and neck cancer

✍ Ansell, A.; Jerhammar, F.; Ceder, R.; Grenman, R.; Roberg, K. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 42 KB

Decreased cisplatin/DNA adduct formation

Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines

✍ Zejia Yang; Patrick J. Faustino; Paul A. Andrews; Rachelle Monastra; Audrey A. R 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 181 KB

Synergistic interaction between cisplati

Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell lines

✍ Bunzo Nakata, Kathleen D. Albright… 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 821 KB

Glutathione content but not gamma glutam

Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines

✍ Kenneth Newkirk; Joseph Heffern; Erik Sloman-Moll; Roy B. Sessions; Audrey A. Ra 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 569 KB

Resistance to EGFR kinase inhibitor PD15

Resistance to EGFR kinase inhibitor PD158780 in head and neck cancer cell lines

✍ Mark James Jameson; Andrew D. Beckler; Christopher Y. Thomas; Michael J. Weber; 📂 Article 📅 2004 🏛 SAGE Publications 🌐 English ⚖ 35 KB

Intrinsic differences in cisplatin sensi

Intrinsic differences in cisplatin sensitivity of head and neck cancer cell lines: Correlation to lysosomal pH

✍ Cathrine Nilsson; Karin Roberg; Roland C. Grafström; Karin Öllinger 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB 👁 2 views

## Abstract ## Background Cisplatin treatment is beneficial for approximately 20% of patients with head and neck squamous cell carcinoma (HNSCC). Tools to predict the clinical outcome and evaluate intrinsic cisplatin sensitivity are, therefore, required. ## Methods Cisplatin sensitivity, lysosom